Aggerholm-Pedersen, N.; Friis, H.N.; Baad-Hansen, T.; Møller, H.J.; Sandfeld-Paulsen, B.
Macrophage Biomarkers sCD163 and sSIRPα in Serum Predict Mortality in Sarcoma Patients. Cancers 2023, 15, 1544.
https://doi.org/10.3390/cancers15051544
AMA Style
Aggerholm-Pedersen N, Friis HN, Baad-Hansen T, Møller HJ, Sandfeld-Paulsen B.
Macrophage Biomarkers sCD163 and sSIRPα in Serum Predict Mortality in Sarcoma Patients. Cancers. 2023; 15(5):1544.
https://doi.org/10.3390/cancers15051544
Chicago/Turabian Style
Aggerholm-Pedersen, Ninna, Henriette Nymark Friis, Thomas Baad-Hansen, Holger Jon Møller, and Birgitte Sandfeld-Paulsen.
2023. "Macrophage Biomarkers sCD163 and sSIRPα in Serum Predict Mortality in Sarcoma Patients" Cancers 15, no. 5: 1544.
https://doi.org/10.3390/cancers15051544
APA Style
Aggerholm-Pedersen, N., Friis, H. N., Baad-Hansen, T., Møller, H. J., & Sandfeld-Paulsen, B.
(2023). Macrophage Biomarkers sCD163 and sSIRPα in Serum Predict Mortality in Sarcoma Patients. Cancers, 15(5), 1544.
https://doi.org/10.3390/cancers15051544